BlackRock Investment Management’s CASI Pharmaceuticals CASI Stock Holding History

BlackRock Investment Management’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4K	Hold	338	–	–	﹤0.01%	3793
2016 Q3	$4K	Buy	338 +58	+21%	+$636	﹤0.01%	3805
2016 Q2	$3K	Hold	280	–	–	﹤0.01%	3923
2016 Q1	$3K	Hold	280	–	–	﹤0.01%	3903
2015 Q4	$3K	Hold	280	–	–	﹤0.01%	3947
2015 Q3	$3K	Hold	280	–	–	﹤0.01%	4026
2015 Q2	$5K	Sell	280 -48	-15%	-$718	﹤0.01%	3952
2015 Q1	$5K	Hold	328	–	–	﹤0.01%	3850
2014 Q4	$4K	Hold	328	–	–	﹤0.01%	3957
2014 Q3	$6K	Buy	+328	New	+$5.83K	﹤0.01%	3841

Other funds holding CASI

WSCM

Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

WSC

Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Investment Management's CASI Position: Q4 2016 in Review

BlackRock Investment Management held its CASI Pharmaceuticals (CASI) position steady in Q4 2016 at 338 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3793.

BlackRock Investment Management first reported a position in CASI in Q3 2014 and has held it in 10 quarters since. The position peaked at $6K in Q3 2014. 28 funds tracked by Wall St. Rank hold CASI as of Q4 2016.

BlackRock Investment Management held 338 shares of CASI Pharmaceuticals worth $4K as of Q4 2016.
BlackRock Investment Management left its CASI Pharmaceuticals share count unchanged in Q4 2016.
CASI Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3793 holding.
BlackRock Investment Management first reported a position in CASI Pharmaceuticals in Q3 2014 and has held it in 10 quarters since.
BlackRock Investment Management's CASI Pharmaceuticals position peaked at $6K in Q3 2014.
28 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.